| Price | 240.00p on 09-07-2025 at 08:40:08 |
|---|---|
| Change | 8.00p 3.45% |
| Buy | 240.00p |
| Sell | 234.00p |
| Buy / Sell HCM Shares | |
| Last Trade: | Buy 1,008.00 at 240.00p |
| Day's Volume: | 7,698 |
| Last Close: | 232.00p |
| Open: | 239.00p |
| ISIN: | KYG4672N1198 |
| Day's Range | 239.00p - 240.00p |
| 52wk Range: | 187.50p - 336.00p |
| Market Capitalisation: | £2,053m |
| VWAP: | 239.45596p |
| Shares in Issue: | 855m |
Sector: Medicine and Biotech
Listed In: FTSE AIM 100, FTSE AIM All-Share,
Hutchmed (HCM) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 1,008 | 240.00p | Ordinary |
08:42:39 - 09-Jul-25 |
| Buy* | 143 | 240.00p | Automatic Execution |
08:33:38 - 09-Jul-25 |
| Buy* | 459 | 240.00p | Automatic Execution |
08:28:16 - 09-Jul-25 |
| Buy* | 2,000 | 240.00p | Automatic Execution |
08:22:32 - 09-Jul-25 |
| Sell* | 100 | 238.00p | Ordinary |
08:21:14 - 09-Jul-25 |
| Sell* | 38 | 239.00p | Ordinary |
08:03:44 - 09-Jul-25 |
| Buy* | 120 | 239.00p | Automatic Execution |
08:03:43 - 09-Jul-25 |
| Buy* | 3,229 | 239.00p | Automatic Execution |
08:03:43 - 09-Jul-25 |
| Buy* | 601 | 239.00p | Automatic Execution |
08:03:43 - 09-Jul-25 |
| Buy* | 1 | 235.00p | Ordinary |
15:16:27 - 08-Jul-25 |
Hutchmed (HCM) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 3rd Jul 2025 9:30 am | RNS | HUTCHMED to Announce 2025 Half-Year Results |
| 2nd Jul 2025 10:00 am | RNS | Update on Joint Corporate Brokers in London |
| 30th Jun 2025 9:30 am | RNS | China Approval based on Phase III SACHI Trial |
| 30th Jun 2025 9:30 am | RNS | Total Voting Rights |
| 30th Jun 2025 9:30 am | RNS | Blocklisting Six Monthly Return |
| 10th Jun 2025 11:00 am | RNS | Grant of Share Options and Awards under LTIP |
| 5th Jun 2025 7:00 am | RNS-R | HUTCHMED and Innovent Announce NDA Acceptance |
| 2nd Jun 2025 7:00 am | RNS-R | HUTCHMED Highlights SACHI Phase III Data at ASCO |
| 30th May 2025 9:30 am | RNS | Total Voting Rights |
| 23rd May 2025 7:00 am | RNS-R | HUTCHMED Highlights Data to be Presented at ASCO |
